CAMP4 Therapeutics Corporation (CAMP)

CAMP4 Therapeutics Corporation (CAMP) scores 30 out of 100 on boothcheck's 11-model valuation framework. Verdict: Strong Avoid The estimated fair value is $0.14, representing a 97% premium to fair value. Quantitative score: 48/100. Qualitative score: 20/100.

Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.

View full CAMP analysis on boothcheck